Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Phase I
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Phase I
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Phase I
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Phase I
Incyte Announces the Validation by the European Medicines Agency of its…
Phase I
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Phase I
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Clinical
Phase I
Phase I
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase I
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany Swiss Stock Exchange:RO
Globenewswire News
-
February 26, 2021
Phase I
Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell...
Phase I
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination Therapy for the Treatment of Chronic Hepatitis B Virus Nasdaq:ABUS
Phase I
EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19 Swiss Stock Exchange:RO
Phase I
4D Pharma Announces U.S. SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQ
Phase I
Roche receives positive CHMP opinion for Evrysdi, the first and only...
Globenewswire News
-
February 26, 2021
0
Phase I
GC Pharma Submits Biologics License Application to US FDA for Immune...
Biospace News
-
February 26, 2021
0
Phase I
Transparency Notification Brussels Stock Exchange:ACPH
Globenewswire News
-
February 26, 2021
0
Phase I
New Data Presented at ACTRIMS Forum 2021 Indicate MAVENCLAD-treated RMS Patients...
Firstwordpharma News
-
February 26, 2021
0
Phase I
FDA clears Sarepta’s exon-skipping therapy Amondys 45 for DMD – FirstWord...
Firstwordpharma News
-
February 26, 2021
0
1
2
3
...
124
Page 1 of 124
- Advertisement -
MOST POPULAR
Incyte to pay $750 million upfront under deal with MorphoSys to...
January 13, 2020
AACR Roundup: Clovis, MiNA Therapeutics, Noxxon and More
April 2, 2019
Tetra Bio-Pharma Receives FDA Orphan Drug Designation for Hepatocellular Carcinoma
December 4, 2019
Paratek Pharmaceuticals Broadens Clinical Profile of NUZYRA (Omadacycline) with New ECCMID...
April 15, 2019
Load more
HOT NEWS
Deals
Zhittya Genesis Medicine Signs $151.5 Million Biopharmaceutical Marketing Partnership Agreement with...
Therapy areas
Expert says pneumonia still top killer of PH kids, bats for...
Phase III
Apellis’ PNH Drug Beats Alexion’s Soliris in Phase III Trial
Commercial
Intec Pharma Announces Pricing of $6.5 Million Public Offering
